141 related articles for article (PubMed ID: 25368288)
1. Predicting overall survival in patients with brain metastases from esophageal cancer.
Rades D; Dziggel L; Bartscht T; Gliemroth J
Anticancer Res; 2014 Nov; 34(11):6763-5. PubMed ID: 25368288
[TBL] [Abstract][Full Text] [Related]
2. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.
Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949
[TBL] [Abstract][Full Text] [Related]
3. The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L
Radiat Oncol; 2016 Jul; 11():92. PubMed ID: 27411944
[TBL] [Abstract][Full Text] [Related]
4. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
5. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
6. A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients.
Evers JN; Schild SE; Segedin B; Nagy V; Khoa MT; Trang NT; Rades D
Anticancer Res; 2014 May; 34(5):2455-8. PubMed ID: 24778060
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with improved survival in patients with brain metastases from esophageal cancer: a retrospective review.
Khuntia D; Sajja R; Chidel MA; Lee SY; Rice TW; Adelstein DJ; Carlson TP; Saxton JP; Barnett GH; Suh JH
Technol Cancer Res Treat; 2003 Jun; 2(3):267-72. PubMed ID: 12779356
[TBL] [Abstract][Full Text] [Related]
8. Brain metastasis in patients with esophageal carcinoma.
Yoshida S
Surg Neurol; 2007 Mar; 67(3):288-90. PubMed ID: 17320640
[TBL] [Abstract][Full Text] [Related]
9. A New Predictive Tool for Optimization of the Treatment of Brain Metastases from Colorectal Cancer After Stereotactic Radiosurgery.
Rades D; Dahlke M; Gebauer N; Bartscht T; Hornung D; Trang NT; Phuong PC; Khoa MT; Gliemroth J
Anticancer Res; 2015 Oct; 35(10):5515-8. PubMed ID: 26408718
[TBL] [Abstract][Full Text] [Related]
10. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
11. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
12. Predicting survival after whole-brain irradiation for cerebral metastases from prostate cancer.
Bartscht T; Rades D
Anticancer Res; 2014 Aug; 34(8):4357-60. PubMed ID: 25075071
[TBL] [Abstract][Full Text] [Related]
13. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
14. Estimation of the Six-month Survival Probability After Radiosurgery for Brain Metastases from Kidney Cancer.
Janssen S; Dahlke M; Trang NT; Khoa MT; Rades D
Anticancer Res; 2015 Jul; 35(7):4215-7. PubMed ID: 26124381
[TBL] [Abstract][Full Text] [Related]
15. Radiosurgery to palliate symptoms in brain metastases from uterine cervix cancer.
Chung SB; Jo KI; Seol HJ; Nam DH; Lee JI
Acta Neurochir (Wien); 2013 Mar; 155(3):399-405. PubMed ID: 23238944
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
18. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for patients with esophageal cancer treated with radiation therapy in PCS: a preliminary study.
Tanisada K; Teshima T; Ikeda H; Abe M; Yamashita T; Nishio M; Inoue T; Hiraoka M; Hirokawa Y; Oguchi M; Yamada S; Sakai K; Nishimura T; Chatani M
Radiat Med; 1998; 16(6):461-8. PubMed ID: 9929147
[TBL] [Abstract][Full Text] [Related]
20. Identifying melanoma patients with 1-3 brain metastases who may benefit from whole-brain irradiation in addition to radiosurgery.
Huttenlocher S; Sehmisch L; Schild SE; Blank O; Hornung D; Rades D
Anticancer Res; 2014 Oct; 34(10):5589-92. PubMed ID: 25275060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
